Contract V797D60655
Pharmaceutical Specialties Inc · Department Of Veterans Affairs · September 3, 2024
Pharmaceutical Specialties Inc was awarded a federal contract by Department Of Veterans Affairs on September 3, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 8, 2025. If all options are exercised, the contract could reach $11.71 million.
Contract details
- PIID
- V797D60655
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medicated Cosmetics And Toiletries
- First action
- September 3, 2024
- Latest action
- September 8, 2025
Description
65IB: TEMPORARY CONTRACT EXTENSION
Modification timeline
-
September 8, 2025Mod P00014 · Supplemental Agreement For Work Within Scope$0
-
September 3, 2024Mod P00012 · Supplemental Agreement For Work Within Scope$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D60655?
Contract V797D60655 is a federal contract awarded to Pharmaceutical Specialties Inc by Department Of Veterans Affairs on September 3, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract V797D60655?
Pharmaceutical Specialties Inc won contract V797D60655 from Department Of Veterans Affairs.
How much is contract V797D60655 worth?
Contract V797D60655 has obligated $0 to date but carries a potential ceiling of $11.71 million if fully funded and all options are exercised.